Results of Percutaneous Coronary Intervention of the Unprotected Left Main Coronary Artery in 143 Patients and Comparison of 30-Day Mortality to Results of Coronary Artery Bypass Grafting

American Journal of Cardiology

Volumn 101, Issue 1, 2008, Pages 75-81

  Dubois, Christophe ^a   Dens, Joseph ^a   Sinnaeve, Peter ^a   Belmans, Ann ^a,b   Van Cleemput, Johan ^a   Mendez, Manuel ^a   Piessens, Jan ^a   Desmet, Walter ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; RAPAMYCIN; THIENOPYRIDINE; TIROFIBAN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADVERSE OUTCOME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BLOOD CLOTTING TIME; CLINICAL FEATURE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; EUROPE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMPLANTATION; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; STENT; SURGICAL MORTALITY; SURGICAL RISK;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); RETREATMENT; RISK ADJUSTMENT; SIROLIMUS; STENTS;

EID: 37349002738     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.07.051     Document Type: Article

References (30)

1. Silber S., Albertsson P., Aviles F.F., Camici P.G., Colombo A., Hamm C., Jorgensen E., Marco J., Nordrehaug J.E., Ruzyllo W., et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26 (2005) 804-847
2. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., Jacobs A.K., Kern M.J., King III S.B., Morrison D.A., O'Neill W.W., Schaff H.V., Whitlow P.L., et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113 (2006) 156-175
3. Bottner R.K., and Klein L.W. Do the current ACC/AHA guidelines correctly reflect the attitudes and utilization of PCI in patients with unprotected left main coronary artery stenosis?. Catheter Cardiovasc Interv 64 (2005) 402-405
4. Lee M.S., Kapoor N., Jamal F., Czer L., Aragon J., Forrester J., Kar S., Dohad S., Kass R., Eigler N., et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 47 (2006) 864-870
5. Chieffo A., Morici N., Maisano F., Bonizzoni E., Cosgrave J., Montorfano M., Airoldi F., Carlino M., Michev I., Melzi G., et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 113 (2006) 2542-2547
6. Ong A.T., Serruys P.W., Mohr F.W., Morice M.C., Kappetein A.P., Holmes Jr. D.R., Mack M.J., van den Brand M., Morel M.A., van Es G.A., et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 151 (2006) 1194-1204
7. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
8. Roques F., Nashef S.A., Michel P., Gauducheau E., de Vincentiis C., Baudet E., Cortina J., David M., Faichney A., Gabrielle F., et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15 (1999) 816-822
9. Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., and Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16 (1999) 9-13
10. Roques F., Michel P., Goldstone A.R., and Nashef S.A. The logistic EuroSCORE. Eur Heart J 24 (2003) 881-882
11. Michel P., Roques F., and Nashef S.A. Logistic or additive EuroSCORE for high-risk patients?. Eur J Cardiothorac Surg 23 (2003) 684-687
12. Hosmer D.W., and Lemeshow S. Confidence interval estimates of an index of quality performance based on logistic regression models. Stat Med 14 (1995) 2161-2172
13. Black A., Cortina R., Bossi I., Choussat R., Fajadet J., and Marco J. Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection. J Am Coll Cardiol 37 (2001) 832-838
14. Chieffo A., Stankovic G., Bonizzoni E., Tsagalou E., Iakovou I., Montorfano M., Airoldi F., Michev I., Sangiorgi M.G., Carlino M., Vitrella G., and Colombo A. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 111 (2005) 791-795
15. Karam C., Fajadet J., Cassagneau B., Laurent J.P., Jordan C., Laborde J.C., and Marco J. Results of stenting of unprotected left main coronary artery stenosis in patients at high surgical risk. Am J Cardiol 82 (1998) 975-978
16. Lee R.J., Lee S.H., Shyu K.G., Lin S.C., Hung H.F., Liou J.Y., Cheng J.J., Kuan P., Lin H.S., and Wang C.F. Immediate and long-term outcomes of stent implantation for unprotected left main coronary artery disease. Int J Cardiol 80 (2001) 173-177
17. Park S.J., Kim Y.H., Lee B.K., Lee S.W., Lee C.W., Hong M.K., Kim J.J., Mintz G.S., and Park S.W. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 45 (2005) 351-356
18. Park S.J., Lee C.W., Kim Y.H., Lee J.H., Hong M.K., Kim J.J., and Park S.W. Technical feasibility, safety, and clinical outcome of stenting of unprotected left main coronary artery bifurcation narrowing. Am J Cardiol 90 (2002) 374-378
19. Price M.J., Cristea E., Sawhney N., Kao J.A., Moses J.W., Leon M.B., Costa R.A., Lansky A.J., and Teirstein P.S. Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. J Am Coll Cardiol 47 (2006) 871-877
20. Suarez de Lezo J., Medina A., Romero M., Hernandez E., Pan M., Delgado A., Segura J., Pavlovic D., and Wanguemert F. Predictors of restenosis following unprotected left main coronary stenting. Am J Cardiol 88 (2001) 308-310
21. Takagi T., Stankovic G., Finci L., Toutouzas K., Chieffo A., Spanos V., Liistro F., Briguori C., Corvaja N., Albero R., et al. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation 106 (2002) 698-702
22. Tan W.A., Tamai H., Park S.J., Plokker H.W., Nobuyoshi M., Suzuki T., Colombo A., Macaya C., Holmes Jr. D.R., Cohen D.J., Whitlow P.L., and Ellis S.G. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation 104 (2001) 1609-1614
23. Tanigawa J., Sutaria N., Goktekin O., and Di Mario C. Treatment of unprotected left main coronary artery stenosis in the drug-eluting stent era. J Interv Cardiol 18 (2005) 455-465
24. Valgimigli M., van Mieghem C.A., Ong A.T., Aoki J., Granillo G.A., McFadden E.P., Kappetein A.P., de Feyter P.J., Smits P.C., Regar E., et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation 111 (2005) 1383-1389
25. Ellis S.G., Tamai H., Nobuyoshi M., Kosuga K., Colombo A., Holmes D.R., Macaya C., Grines C.L., Whitlow P.L., White H.J., et al. Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996. Circulation 96 (1997) 3867-3872
26. Park S.J., Park S.W., Hong M.K., Lee C.W., Lee J.H., Kim J.J., Jang Y.S., Shin E.K., Yoshida Y., Tamura T., Kimura T., and Nobuyoshi M. Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Am J Cardiol 91 (2003) 12-16
27. Bhatti F., Grayson A.D., Grotte G., Fabri B.M., Au J., Jones M.T., and Bridgewater B. The logistic EuroSCORE in cardiac surgery: how well does it predict operative risk?. Heart 92 (2006) 1817-1820
28. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
29. Sianos G., Morel M., Kappetein A.P., Morice M.C., Colombo A., Dawkins K.D., van den Brand M., Van Dyck N., Rusell M.E., Mohr F.W., and Serruys P.W. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1 (2005) 219-227
30. Nalysnyk L., Fahrbach K., Reynolds M.W., Zhao S.Z., and Ross S. Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart 89 (2003) 767-772